Volume 27, Number 3—March 2021
Research
Oral Human Papillomavirus Infection in Children during the First 6 Years of Life, Finland
Table 1
Variable | At birth | 3 d | 1 mo | 2 mo | 6 mo | 12 mo | 24 mo | 36 mo | 6 y |
---|---|---|---|---|---|---|---|---|---|
Oral sample | 324 | 309 | 300 | 296 | 295 | 291 | 264 | 265 | 201 |
Mean ± SD age, mo |
0 |
0.08 ± 0.37 |
1.14 ± 0.18 |
2.23 ± 0.33 |
6.41 ± 0.45 |
12.61 ± 0.67 |
24.90 ± 1.01 |
36.98 ± 1.31 |
77.47 ± 11.01 |
Any HPV+ | 74 (22.8) | 41 (13.3) | 57 (19) | 48 (16.2) | 44 (14.9) | 34 (11.7) | 25 (9.5) | 23 (8.7) | 41 (20.4) |
Girls, any HPV+ | 35 (47.9) | 19 (46.3) | 25 (43.9) | 29 (60.4) | 20 (46.5) | 20 (58.5) | 14 (56.0) | 10 (43.5) | 20 (49.9) |
Boys, any HPV+ | 39 (52.1) | 22 (53.7) | 32 (56.1) | 19 (39.6) | 24 (53.5) | 14 (51.5) | 9 (44.0) | 13 (56.5) | 21 (51.2) |
Single HPV+ | 62 (19.1) | 36 (11.7) | 55 (18.3) | 44 (14.8) | 36 (12.2) | 33 (11.0) | 20(7.6) | 21 (7.9) | 35 (17.4) |
Multiple HPV (>2) |
12 (3.7) |
5 (1.6) |
2 (0.7) |
4 (1.4) |
8 (2.7) |
1 (0.3) |
4 (1.5) |
2 (0.8) |
6 (3.0) |
No. HPV genotypes |
15 |
5 |
8 |
7 |
9 |
10 |
7 |
4 |
8 |
Low-risk HPV | |||||||||
HPV6 | 11 (3.4) | 5 (1.6) | 3 (1.0) | 7 (2.4) | 4 (1.4) | 3 (1.0) | 1 (0.4) | 2 (0.8) | 4(2.0) |
HPV11 | 1(0.3) | – | 1 (1.0) | 5 (1.7) | 4 (1.4) | 1 (0.3) | – | 1 (0.4) | – |
HPV70 |
2 (0.6) |
– |
– |
1 (0.3) |
1 (0.3) |
1 (0.3) |
2 (0.8) |
– |
– |
High-risk HPV | |||||||||
HPV16 | 25 (7.7) | 28 (9.1) | 30 (10) | 16 (5.4) | 14 (4.7) | 14 (4.8) | 9 (3.4) | 17 (6.4) | 20(10) |
HPV18 | 4 (1.2) | 1 (0.3) | 9 (3.0) | 11 (3.7) | 7 (2.4) | 8 (2.7) | 4 (1.5) | 1 (0.4) | 2 (1.0) |
HPV31 | 31 (0.9) | – | – | 2 (0.7) | – | 1 (0.3) | – | – | 3 (1.5) |
HPV33 | 2 (0.6) | – | 8 (2.7) | 2 (0.7) | 1 (0.3) | – | 2 (0.8) | – | 2 (1.0) |
HPV39 | 1 (0.3) | – | 1 (0.3) | – | – | – | – | – | 2 (1.0) |
HPV45 | 1 (0.3) | – | 1 (0.3) | – | 1 (0.3) | – | – | – | 1 (0.5) |
HPV51 | – | – | – | – | 1 (0.3) | 1 (0.3) | – | – | – |
HPV52 | – | – | – | – | – | 1 (0.3) | – | – | – |
HPV53 | 1 (0.3) | 1 (0.3) | – | – | … | – | – | – | |
HPV56 | 3 (0.9) | – | – | – | – | 1 (0.3) | 1 (0.4) | – | – |
HPV58 | 2 (0.6) | – | – | – | – | 1 (0.3) | – | – | 1 (0.5) |
HPV66 | 4 (1.2) | 1 (0.3) | 2 (0.7) | – | 1 (0.3) | – | 1 (0.4) | – | – |
HPV68 | 1 (0.3) | – | – | – | – | – | – | – | – |
HPV82 | 1 (0.3) | – | – | – | – | – | – | – | – |
*Values are no. (%) unless indicated otherwise. Two cases where excluded because of missing sample at birth. HPV, human papillomavirus. –, HPV genotype not found at that visit.
1These senior authors contributed equally to this article.
Page created: December 22, 2020
Page updated: February 21, 2021
Page reviewed: February 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.